Where We Work

Unitaid’s impact creates a ripple effect that extends far beyond the borders of the countries where we have projects

Unitaid and

South Africa South Africa

Download PDF

Country Background

Key Indicators (1) Country Region
Total population (000s) 56,015 1,019,922
GDP per capita, PPP in $ 13498 3805
Healthy life expectancy at birth, in years 55.7 53.8
Under 5 mortality rate, per 1,000 live births 43.3 76.5
HIV prevalence 18.8 [16.2 - 20.9] 6.8 [5.9 - 7.7]
New HIV infections among adults 15-49 years old, per 1,000 uninfected population 5.58 1.24
TB incidence, per 100,000 population 781 254
Malaria incidence, per 1,000 population at risk 1.1 239.6

Unitaid investments

$2.9M Completed Projects
$68.8M Current Projects
82% 18%

Current project commitment by disease

HIV and Co-infections

Current Projects

Core Investment Area Project Lead Grantee Project Duration
Building country capacity to support access to medicines South Centre 2018-2021
HIV and Co-Infection
In Africa, a mass media campaign for HIV self-testing and prevention among youth MTV Staying Alive Foundation 2018-2021
Expanding HIV self-testing in Africa Population Services International (PSI) 2017-2020
Preventing HIV in adolescent girls and young women Wits Reproductive Health & HIV Institute 2018-2020
Making the best HIV drugs available more quickly in lower-income countries Clinton Health Access Initiative (CHAI) 2016-2020
Comparing a dolutegravir + darunavir combination to the standard treatment for HIV patients who have failed first-line therapy University of New South Wales (Kirby Institute) 2017-2020
Safer, more robust and less expensive first-line antiretroviral therapy Wits Reproductive Health & HIV Institute 2016-2020
Dolutegravir in pregnant mothers and newborns University of Liverpool 2016-2021
Better HIV treatment for infants and young children Drugs for Neglected Diseases Initiative (DNDi) 2013-2018
, , , , , Better treatments and prevention for drug-resistant tuberculosis in children Stellenbosch University (SU) 2019-2022
, , , High-tech tests for drug-resistant TB Foundation for Innovative New Diagnostics (FIND) 2019-2021
Tuberculosis prevention for high-risk groups Aurum Institute 2017-2021
Shorter, better treatments for multidrug-resistant tuberculosis Partners in Health (PIH) 2015-2022

Other Unitaid investment areas that could benefit this country

HIV diagnostics

Unitaid is working to expand access to HIV self-tests for adults and point-of-care testing for infants to increase HIV diagnosis.

Learn More View Projects
Paediatric tuberculosis treatment

Unitaid is seeking to speed up adoption of treatments and diagnostic tools better suited to children with TB. Nearly 575 children die each day from TB.

Learn More View Projects

Last Update March, 2019

(1) The country and regional data is based on the most up-to-date official statistics provided in WHO’s World Health Statistics Report, The World Bank data, and UNAIDS AIDSInfo.

For all health statistics data please refer to World Health Statistics Report, 2018, available at http://www.who.int/gho/publications/world_health_statistics/2018/en/

For GDP per capita, PPP in $ data, please refer to the World Bank, 2017, available at https://data.worldbank.org/indicator/NY.GDP.PCAP.PP.CD

For HIV prevalence data,  please refer to UNAIDS, AIDSinfo, 2017, available at http://aidsinfo.unaids.org

For more information on financial data presented please refer to Notes to Financial Disclosures on Country Profiles

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.